Skip to content
Screener

Enphase Energy ENPH Business Segments — Other research and development

Similar metrics at other companies

Inhibrx Biosciences, Inc. logo
INBXReportable Segment — Other research and development
$2.91M-7.8%
Travere Therapeutics, Inc. logo
TVTXReportable Segment — Other research and development
$4.84M+9.2%
Alto Neuroscience logo
ANROReportable segment — Other research and development
$1.2M+6.1%
Incyte logo
INCYReportable Segment — Other research and development
$0-100%
Biogen logo
BIIBReportable Segment — Research and development:
$167.1M-0.7%
Inhibrx Biosciences, Inc. logo
INBXReportable Segment — Other Research and Development Expense
$2.91M-7.8%

Other financials

Income statement

See full
Revenue$291.9M-19.6%
Gross profit$175.0M+2.7%
Operating income$51.5M+39.2%
Net income$36.1M-2.6%
EPS (diluted)$0.27-3.6%

Balance sheet

See full
Cash & equivalents$529.3M+42.9%
Total debt$613.4M-50.3%
Total equity$1.2B+34.2%
Total assets$2.9B-8.2%

Cash flow

See full
Operating cash flow$40.3M+51.4%
CapEx$14.4M+74.3%
Free cash flow$25.9M+41.1%

Valuation

See full
Market cap$5.15B+30.7%
Enterprise value$5.23B+9.0%
P/E38.4×+15.9×
P/S3.9×+1.2×

Profitability

See full
Gross margin46.9%-1.3pp
Operating margin8.3%-3.4pp
Net margin10.1%-1.7pp
FCF margin11.5%-13.7pp

Returns & leverage

See full
Return on equity13%-6.8pp
Debt / equity0.5×-0.9×
Current ratio3.5×+1.5×

Where this comes from

Reported directly by Enphase Energy in its filing.

Tagged under the XBRL concept enph:ResearchAndDevelopmentExpenseAdjusted.

The source filing: Enphase Energy’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:29 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001463101-26-000081
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Stock-based compensation expense43,55453,89692,545109,529
Acquisition related expenses and amortization(3)4,2514,4679,4198,896
Other restructuring and asset impairment charges(4)7843,2434,6335,896
Other research and development(5)28,08924,94054,12253,467
Other sales and marketing(6)30,53331,17461,10260,877
Other general and administrative(7)21,19721,66741,54942,860
Income from operations51,51937,00721,87668,929
Total other income, net10,3805,19826,16320,169

Item 1. Financial Statements (unaudited)

FAQ

What is Enphase Energy's business segments — other research and development?
Enphase Energy (ENPH) reported business segments — other research and development of $28.09M in Q2 2026.
How has Enphase Energy's business segments — other research and development changed year-over-year?
Enphase Energy's business segments — other research and development increased by 12.6% year-over-year, from $24.94M to $28.09M.
What is the long-term trend for Enphase Energy's business segments — other research and development?
Over 3 years (2022 to 2025), Enphase Energy's business segments — other research and development has grown at a 2.1% compound annual growth rate (CAGR), from $99.76M to $106.24M.
What does business segments — other research and development mean?
Represents expenditures dedicated to innovation, product development, and engineering improvements outside of core manufacturing costs. This metric indicates the company's commitment to maintaining a competitive technological edge in the solar and storage market. High levels of investment here are typically viewed as a driver for future product differentiation.

Ask your AI about Enphase Energy's business segments — other research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude